bibtype J - Journal Article
ARLID 0565800
utime 20240103231038.2
mtime 20221221235959.9
SCOPUS 85138444993
WOS 000824508800001
DOI 10.1093/infdis/jiac258
title (primary) (eng) Reply to Llibre et al
specification
page_count 1 s.
media_type P
serial
ARLID cav_un_epca*0253827
ISSN 0022-1899
title Journal of Infectious Diseases
volume_id 226
volume 5 (2022)
page_num 941-941
publisher
name Oxford University Press
keyword RNA vaccines
keyword vaccine-specific analyses
keyword Letter to the Editor
author (primary)
ARLID cav_un_auth*0101206
name1 Šmíd
name2 Martin
institution UTIA-B
full_dept (cz) Ekonometrie
full_dept (eng) Department of Econometrics
department (cz) E
department (eng) E
garant K
fullinstit Ústav teorie informace a automatizace AV ČR, v. v. i.
author
ARLID cav_un_auth*0270143
name1 Berec
name2 L.
country CZ
author
ARLID cav_un_auth*0091778
name1 Trnka
name2 J.
country CZ
source
url http://library.utia.cas.cz/separaty/2022/E/smid-0565800.pdf
cas_special
abstract (eng) The letter by Llibre et al states that our study lacks a comparison between individual vaccines, so the authors present their own research on this topic, showing superiority of messenger RNA vaccines over adenovirus-based vaccines.
result_subspec WOS
RIV BC
FORD0 10000
FORD1 10100
FORD2 10102
reportyear 2023
num_of_auth 3
inst_support RVO:67985556
permalink https://hdl.handle.net/11104/0337921
confidential S
mrcbC91 C
mrcbT16-e IMMUNOLOGY|INFECTIOUSDISEASES|MICROBIOLOGY
mrcbT16-j 2.208
mrcbT16-s 2.386
mrcbT16-D Q1
mrcbT16-E Q1*
arlyear 2022
mrcbU14 85138444993 SCOPUS
mrcbU24 PUBMED
mrcbU34 000824508800001 WOS
mrcbU63 cav_un_epca*0253827 Journal of Infectious Diseases 0022-1899 1537-6613 Roč. 226 č. 5 2022 941 941 Oxford University Press